30 related articles for article (PubMed ID: 15216398)
1. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Cheng XD; Lu WG; Ye F; Wan XY; Xie X
J Exp Clin Cancer Res; 2009 Jun; 28(1):91. PubMed ID: 19563645
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women.
Mostaid MS; Mumu SB; Haque MA; Sharmin S; Jamiruddin MR; Sayedur Rahman GM; Reza HM
PLoS One; 2021; 16(12):e0261984. PubMed ID: 34962972
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
[TBL] [Abstract][Full Text] [Related]
4. Association of XRCC1 Trp194 allele with risk of breast cancer, and Ki67 protein status in breast tumor tissues.
Jalali C; Ghaderi B; Amini S; Abdi M; Roshani D
Saudi Med J; 2016 Jun; 37(6):624-30. PubMed ID: 27279507
[TBL] [Abstract][Full Text] [Related]
5. p53 polymorphisms: cancer implications.
Whibley C; Pharoah PD; Hollstein M
Nat Rev Cancer; 2009 Feb; 9(2):95-107. PubMed ID: 19165225
[TBL] [Abstract][Full Text] [Related]
6. Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients.
Toyama T; Zhang Z; Nishio M; Hamaguchi M; Kondo N; Iwase H; Iwata H; Takahashi S; Yamashita H; Fujii Y
Breast Cancer Res; 2007; 9(3):R34. PubMed ID: 17537232
[TBL] [Abstract][Full Text] [Related]
7. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
8. TP53 codon 72 polymorphism and susceptibility to cervical cancer in the Chinese population: an update meta-analysis.
Li B; Wang X; Chen H; Shang LX; Wu N
Int J Clin Exp Med; 2015; 8(6):9055-62. PubMed ID: 26309559
[TBL] [Abstract][Full Text] [Related]
9. XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis.
Mei J; Duan HX; Wang LL; Yang S; Lu JQ; Shi TY; Zhao Y
Tumour Biol; 2014 Feb; 35(2):1221-31. PubMed ID: 24057881
[TBL] [Abstract][Full Text] [Related]
10. The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan.
Djansugurova LB; Perfilyeva AV; Zhunusova GS; Djantaeva KB; Iksan OA; Khussainova EM
Front Genet; 2013; 4():70. PubMed ID: 23675381
[TBL] [Abstract][Full Text] [Related]
11. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.
El khair MM; Ennaji MM; El kebbaj R; Mhand RA; Attaleb M; El Mzibri M
Med Oncol; 2010 Sep; 27(3):861-6. PubMed ID: 19771536
[TBL] [Abstract][Full Text] [Related]
12. Association of specific genotype and haplotype of p53 gene with cervical cancer in India.
Mitra S; Misra C; Singh RK; Panda CK; Roychoudhury S
J Clin Pathol; 2005 Jan; 58(1):26-31. PubMed ID: 15623478
[TBL] [Abstract][Full Text] [Related]
13. No association between polymorphisms of the DNA repair geneXRCC1 and cervical neoplasm risk.
Wu MT; Chen SY; Wu TN; Hwang HY; Ho CK; Lee LH; Wu SC
Environ Health Prev Med; 2003 Jul; 8(3):100-3. PubMed ID: 21432107
[TBL] [Abstract][Full Text] [Related]
14. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
15. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas.
Hsieh LL; Chien HT; Chen IH; Liao CT; Wang HM; Jung SM; Wang PF; Chang JT; Chen MC; Cheng AJ
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):439-43. PubMed ID: 12750239
[TBL] [Abstract][Full Text] [Related]
16. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
17. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review.
Koushik A; Platt RW; Franco EL
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):11-22. PubMed ID: 14744727
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women.
Wu MT; Liu CL; Ho CK; Wu TN
J Formos Med Assoc; 2004 May; 103(5):337-43. PubMed ID: 15216398
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
